BioSpace News Archive

Policy

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

Belantamab mafodotin accepted for accelerated assessment by the EMA’s Committee for Human Medicinal Products (CHMP)

February 3, 2020

·

7 min read

Job Trends

Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France

Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either a BRCA1/2 mutation or are BRCA wild-type

February 3, 2020

·

11 min read

Biotech Beach

Calidi Biotherapeutics Announces Abstract Acceptance for Presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium

Calidi Biotherapeutics, Inc. announced the acceptance of an abstract for presentation at the ASCO-SITC Clinical Immuno-Oncology Symposium, which is being held February 6 to February 8, 2020, at the Rosen Shingle Creek Resort in Orlando, Florida.

February 3, 2020

·

3 min read

Policy

Mesoblast Submits Completed Biologics License Application for Ryoncil™ to US FDA

Mesoblast Limited announced that it has submitted its completed Biologics License Application to the United States Food and Drug Administration for Ryoncil™, its lead allogeneic cell therapy for the treatment of children with steroid-refractory acute graft versus host disease.

February 3, 2020

·

5 min read

Policy

United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint

United Therapeutics Corporation announced topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin® Injection added to irinotecan compared to irinotecan or topotecan alone in patients with relapsed or refractory small cell lung cancer.

February 3, 2020

·

14 min read

Deals

BiomX Announces Dual Listing on the Tel-Aviv Stock Exchange

BiomX Inc. announced that the Tel Aviv Stock Exchange has approved the listing of its common shares, with trading effective February 6th, 2020.

February 3, 2020

·

3 min read

Deals

Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Stock option award offered as inducement to Ivor Macleod, new Chief Financial Officer of Athersys

February 3, 2020

·

2 min read

Business

Amir Shojaei, PharmD, PhD, to Join iVeena Board of Directors

iVeena Delivery Systems, Inc., a clinical stage biopharmaceutical company with developmental products in cornea and cataract, announces the appointment of Dr. Amir Shojaei to the iVeena Board of Directors.

February 3, 2020

·

2 min read

Biotech Beach

AntiCancer Inc. to Target Its Oral Recombinant Methioninase Against 2019-nCoV Coronavirus

Currently there are no therapies or vaccines for patients infected with 2019-nCoV coronavirus around the world.

February 3, 2020

·

1 min read

Business

Centene Appoints Chris Koster to Senior Vice President, Secretary and General Counsel and Keith Williamson to President of the Centene Charitable Foundation

Centene Corporation announced the appointment of Chris Koster to Senior Vice President, Secretary and General Counsel, effective February 19, 2020.

February 3, 2020

·

9 min read